Alcon Inc. (2U3)
XETRA Stock Exchange · Germany · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 62.66 |
|---|---|
| 52-week range | 52.42 – 74.62 |
| Return, 1 month / 3 months | +9.1% / +6.2% |
| Return, 1 year / 3 years | −2.9% / – |
| Trend | Uptrend |
| RSI (14) | 70 |
| Volatility (1 year) | 28.2% |
| Worst drawdown (1 year) | -27.4% |
| Average daily value traded | 0.22M EUR |
| Dividend yield | 0.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Alcon is an eye care company based in Switzerland that develops products for vision and eye health. It makes surgical equipment and devices used by eye surgeons for procedures such as cataract and retinal surgery, and it supplies contact lenses and lens care products. The company also offers ophthalmic medicines, including eye drops for conditions such as dry eye and glaucoma. Its customers are eye care professionals, hospitals, clinics and consumers around the world.
The shares are listed on the XETRA Stock Exchange in Germany under the code 2U3, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in one calendar year. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Alcon Inc. (2U3) trades on the XETRA Stock Exchange in Germany. It last closed at EUR 62.66 on 23 October 2026.
Its price-based Market X-Ray is 51 out of 100 (a fair price profile), ranking 374 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 2.9% and over the last three months it rose 6.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on XETRA Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 54 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 1.0% | ||
| From 52-week high | -14.9% | ||
| Momentum | 52 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 6.2% | ||
| 6-month return | -3.5% | ||
| 12-month return, skipping the last month | -11.0% | ||
| Stability (higher is calmer) | 66 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 28.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -27.4% | ||
| Liquidity | 55 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.22M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 5 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.5% | ||
| Years with dividends | 1 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | +6.0% |
|---|---|
| 1 month | +9.1% |
| 3 months | +6.2% |
| 6 months | −3.5% |
| 1 year | −2.9% |
| 3 years | – |
| 5 years | – |
Signals
| 50-day / 200-day average | 59.35 / 62.03 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.15 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 5 May 2026 | CHF 0.3022 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on XETRA Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.